Bentham Science Logo

Track Your Manuscript:


Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 12 - Number 4




VIP in Inflammatory Bowel Disease: State of the Art

, 12(4): 316 - 322

Catalina Abad, Rosa Gomariz, James Waschek, Javier Leceta, Carmen Martinez, Yasmina Juarranz and Alicia Arranz


DOI: 10.2174/187153012803832576








Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes

, 12(4): 377 - 381

Vincenzo Triggiani, Vito Angelo Giagulli, Angela Tafaro, Francesco Resta, Carlo Sabba, Brunella Licchelli and Edoardo Guastamacchia


DOI: 10.2174/187153012803832558



Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Scopus CiteScore Metrics: 1.79

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi


Advertisement

How to write and publish your papers in high impact journalsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog